Ziwei Wang

Ziwei Wang practices at West Los Angeles Medical Center in Los Angeles, California, part of Kaiser Permanente.

Ziwei Wang's NPI, 1760914436, was assigned on March 31, 2017. Ziwei Wang graduated from UC San Diego School of Medicine in 2017. Ziwei Wang holds California license A162653.

Ziwei Wang's primary practice is West Los Angeles Medical Center, at 6041 Cadillac Ave, Los Angeles, CA 90034 in Los Angeles County. The practice phone is (213) 857-2201.

Ziwei Wang's primary practice is West Los Angeles Medical Center in Los Angeles, California, part of Kaiser Permanente. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Ziwei Wang to 1 more dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ziwei Wang practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Ziwei Wang's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Ziwei Wang is board certified in allergy & immunology by the American Board of Allergy and Immunology. Ziwei Wang is licensed in California.

Dmand AI lists immune deficiency disease among the conditions Ziwei Wang treats.

CMS data shows 889 Medicare services from Ziwei Wang across 6 procedure codes in 2024, for 115 Medicare patients. Medicare paid $16,338 for them. Every service was in an office.

CMS counts 115 Medicare patients who saw Ziwei Wang in 2024. The largest group is 65 to 74, with 60 patients. 74% of them have high cholesterol, and 60% have arthritis. 33% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ziwei Wang's median patient age at 36, with 65% women.

In 2024, Ziwei Wang wrote 186 Medicare Part D claims for 62 patients. 68% of them were for generic drugs. CMS names the drug for 106 of them, across 6 drugs with 11 or more claims each, at $47,197 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Ziwei Wang for performance year 2024, reported as part of a group. Ziwei Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Ziwei Wang, published from 2018 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Catechin and Diet, High-Fat. Ziwei Wang's most frequent co-authors are Priya J. Bansal, MD, Manish Janardhan Butte, MD, PhD and Jaspreet K. Dhami, MD.

CMS Open Payments shows 24 general payments to Ziwei Wang from 11 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $443.

Ziwei Wang graduated from UC San Diego School of Medicine in 2017.

Ziwei Wang is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.